Dynacirc and Ulo drug interactions - a phase IV clinical study of FDA data
Summary:
We study 32,201 people who take Dynacirc (isradipine) and Ulo (chlophedianol hydrochloride). There is no drug interaction reported.
The study analyzes what interactions people have when they take Dynacirc and Ulo. It is created by eHealthMe based on reports the from the FDA, and is updated regularly.
What is Dynacirc?
Dynacirc has active ingredients of isradipine. eHealthMe is studying from 975 Dynacirc users. Check the latest studies of Dynacirc.
What is Ulo?
Ulo has active ingredients of chlophedianol hydrochloride.
No report is found.
Do you take Dynacirc and Ulo?
- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously
Related studies:
Effectiveness of, side effects of, and alternative drugs to the 2 drugs:
How the study uses the data?
The study uses data from the FDA. It is based on isradipine and chlophedianol hydrochloride (the active ingredients of Dynacirc and Ulo, respectively), and Dynacirc and Ulo (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.
How to use the study?
DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.
Who is eHealthMe?
With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.
Recent studies on eHealthMe:
- Escitalopram and Enlarged Prostate for Men aged 60+ - 19 seconds ago
- Escitalopram and Bhp for Men aged 60+ - 19 seconds ago
- Escitalopram and Benign Prostatic Hyperplasia for Men aged 60+ - 19 seconds ago
- Escitalopram and Prostate Examination Abnormal for Men aged 60+ - 20 seconds ago
- Escitalopram and Nodular Hyperplasia for Men aged 60+ - 20 seconds ago
- Escitalopram and Bph for Men aged 60+ - 20 seconds ago
- Escitalopram and Bep for Men aged 60+ - 21 seconds ago
- Escitalopram and Benign Enlargement Of The Prostate for Men aged 60+ - 21 seconds ago
- Rybelsus and High Blood Pressure for Women aged 60+ - 31 seconds ago
- Rybelsus and Blood Pressure Increased for Women aged 60+ - 32 seconds ago